未登録の方はこちらから登録できます。
TEL．03-5812-5270
FAX．03-3831-0495
E-mail：info@spi-information.com
市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。
当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。
World Smoking-Cessation Drug Market 2010-2025
世界の禁煙薬市場2010−2025
- この重要な依存症治療薬市場は今後どのように拡大していくのでしょうか。このレポートが明らかにします。
喫煙は世界で最も予防が可能な死亡原因です。2009年における禁煙補助医薬品の市場規模は16億ドルを超えています。喫煙の影響は公的医療制度の大きな足かせになるのと同時に、多くの人の生活の質（QOL）を低下させます。現在販売されている禁煙補助薬は実際にはあまり効果がなく、また顕著な副作用を伴うものが一般的です。したがって新規の、より効果的で安全な禁煙補助薬に関しては、特に処方薬に有望な市場機会があります。このレポートは禁煙市場が2010〜2025年の15年間でどのように推移するかを予測します。
Visiongainの予測によれば、今後10年間の早期に新しい禁煙補助薬が発売されることによって禁煙医薬品に対する現在のアンメットニーズはいくらか解決されるでしょう。現在販売されている製品のほか、開発中の最も有望な製品についても幅広く分析をしています。また独自調査によって得られた様々な意見も載せています。このレポートは北米、ヨーロッパ、アジアの主要市場を詳細に分析します。今後15年間はインド、中国をはじめとする新興諸国がこの市場に大きく貢献すると予想されます。世界の喫煙人口のほぼ半数がこれらの国々で占められ、中国だけでも全体の3分の1を占めています。これらの地域における禁煙補助薬の売上は比較的少ないのが現状ですが、新興国では今後これらの医薬品が大きく売上を伸ばす可能性を持っています。
これらの国々で今後15年間に売上、市場シェアがどれ位拡大していくのか、このレポートが明らかにします。現在、世界の喫煙者の大多数が禁煙治療薬を十分に使用することができない状況にあります。喫煙に関連した経済的、社会的コストが増大しているため、各国政府は禁煙法の制定をやタバコ依存症治療に対する予算の増額といった対策を講じています。2010−2015年の間、タバコ規制政策の実施、拡大‐特に公共の場所での禁煙条例−が続くでしょう。これらの政策が全て実行されることによって禁煙治療薬の使用が増えますが、それが技術的、商業的に進展を見るにはまだ多くの課題が残されています。
このレポートのポイント：
- 禁煙治療薬市場の売上予測、主要な治療薬の種類、世界レベルでのトップ製品
- 米国、カナダ、英国、フランス、ドイツ、スウェーデン、デンマーク、日本、中国、インドにおける禁煙薬市場の詳細な調査、分析と売上予測
- この市場の強み、弱点、事業機会、脅威に関する分析
- 禁煙治療薬のR&Dパイプライン分析
目次
Table of Contents
1. Executive Summary
2. Introduction to Smoking Cessation
2.1 Tobacco
2.1.1 Types of Tobacco Consumption
2.1.2 Tobacco Addiction is a Major Global Health Problem
2.2 Nicotine Addiction
2.3 Smoking Cessation
2.3.1 Why is it Difficult to Stop Smoking?
2.3.2 Methods for Smoking Cessation
3. Pharmacological Smoking-Cessation Products
3.1 Nicotine Replacement Therapy (NRT)
3.1.1 Nicorette NRT (Johnson & Johnson/Takeda)
3.1.2 Nicabate/NicoDerm/Nicorette/NiQuitin NRT Brands (GSK)
3.1.3 Novartis NRT Brands
3.1.4 Other NRT Manufacturers
3.2 Chantix/Champix (varenicline, Pfizer)
3.3 Bupropion
3.3.1 Zyban (GSK/Biovail)
3.3.2 Generic Bupropion Drugs
3.4 Off-Label Drug Prescribing for Smoking Cessation
4. The World Smoking-Cessation Market
4.1 The World Smoking-Cessation Market Value, 2008-2009
4.1.1 Smoking-Cessation Market Value
4.1.2 Leading Smoking-Cessation Product Types
4.1.3 Leading Smoking-Cessation Brands
4.1.4 Leading Smoking-Cessation Manufacturers
4.2 The World Smoking-Cessation Market Forecast, 2010-2025
4.2.1 Growth in the Smoking-Cessation Market, 2010-2025
4.2.2 Emerging Products and Sales Forecast of the Smoking-Cessation Market, 2010-2025
4.2.3 Smoking-Cessation Market from 2010-2020
4.2.4 Market Acceleration from 2020 to 2025
4.2.5 Smoking-Cessation Product Type Sales Forecast, 2010-2025
5. Individual Market Forecasts for Leading Drugs, 2010-2025
5.1 Nicotine Replacement Therapies Sales Forecast, 2010-2025
5.1.1 Individual NRT Sales Forecast, 2010-2025
5.1.2 Upper Level NRT Sales Forecast, 2010-2025
5.1.3 Lower Level NRT Sales Forecast, 2010-2025
5.2 Chantix/Champix Sales Forecast, 2010-2025
5.3 Bupropion Smoking-Cessation Drugs Sales Forecast, 2010-2025
6. Geographical Breakdown of the Smoking-Cessation Market, 2010-2025
6.1 The Leading Smoking-Cessation Markets
6.2 Leading Smoking-Cessation Country Markets and Sales Forecast, 2010-2025
6.3 The US Smoking-Cessation Market
6.3.1 Smoking Prevalence Declining in US
6.3.2 Availability and Reimbursement of Smoking-Cessation Aids in the US
6.3.3 US Smoking-Cessation Market Revenue, 2008-2009
6.3.4 Is there Scope for US Smoking-Cessation Market Expansion?
6.3.5 US Smoking-Cessation Market Forecast, 2010-2025
6.4 The UK Smoking-Cessation Market
6.4.1 Tobacco Use in the UK
6.4.2 The UK Pioneers Smoking-Cessation Reimbursement and OTC Retailing of NRT Products
6.4.3 The UK is Europe’s Largest Smoking-Cessation Market
6.4.4 UK Government Anti-Smoking Legislation Lifts Market
6.4.5 UK Smoking-Cessation Market Forecast, 2010-2025
6.5 The Canadian Smoking-Cessation Market
6.5.1 Current Smoking Prevalence in Canada
6.5.2 Availability and Reimbursement of Smoking-Cessation Products in Canada
6.5.3 Factors Affecting the Canadian Smoking-Cessation Market
6.5.4 Canadian Smoking-Cessation Market Forecast, 2010-2025
6.6 The Japanese Smoking-Cessation Market
6.6.1 Japan has a Relatively Undeveloped Smoking-Cessation Market
6.6.2 The Japanese Smoking-Cessation Market, 2008-2010
6.6.3 Japanese Smoking-Cessation Market Forecast, 2010-2025
6.7 The French Smoking-Cessation Market
6.7.1 French Smoking Prevalence
6.7.2 The French Smoking-Cessation Market, 2008-2009
6.7.3 French Government's Provision of Smoking-Cessation Aids is Better than that in Many Other European Countries
6.7.4 French Smoking-Cessation Market Forecast, 2010-2025
6.8 The Swedish Smoking-Cessation Market
6.8.1 Snus in Sweden Increasing in Prevalence
6.8.2 The Swedish Smoking-Cessation Market in 2008-2009
6.8.3 Swedish Smoking-Cessation Market Forecast, 2010-2025
6.9 The Danish Smoking-Cessation Market
6.9.1 Smoking Prevalence Still High in Denmark
6.9.2 Danish Smoking-Cessation Market Forecast, 2010-2025
6.10 The German Smoking-Cessation Market
6.10.1 The German Smoking-Cessation Market, 2007-2008
6.10.2 Factors Holding Back the German Smoking-Cessation Market
6.10.3 German Smoking-Cessation Market Forecast, 2010-2025
7. Emerging Countries in the Smoking-Cessation Market
7.1 Greatest Market Growth Predicted in India and China
7.2 The Indian Smoking-Cessation Market
7.2.1 Tobacco in India is Both Smoked and Chewed
7.2.2 The Indian Smoking-Cessation Market, 2008-2009
7.2.3 Indian Smoking-Cessation Market Still in its Infancy
7.2.4 Prospects for Growth of the Indian Smoking-Cessation Market
7.2.5 Indian Smoking-Cessation Market Forecast, 2010-2025
7.3 The Chinese Smoking-Cessation Market
7.3.1 More than 5 Billion Cigarettes are Smoked in China Every Day
7.3.2 The Chinese Smoking-Cessation Market, 2008-2009
7.3.3 The Chinese Smoking-Cessation Market is Currently Undeveloped
7.3.4 Smoking-Cessation Market Prospects in China and Hong Kong
7.3.5 Chinese Smoking-Cessation Market Forecast, 2010-2025
8. Issues Affecting the Smoking-Cessation Market, 2010-2025
8.1 SWOT Analysis of the Global Smoking-Cessation Market
8.2 Strengths of the Smoking-Cessation Sector
8.2.1 Innovation in Smoking-Cessation Therapies
8.2.2 Innovative Marketing Techniques
8.2.3 Support Plans and Web 2.0 Technology in Combination with Pharmacotherapy
8.2.4 OTC-Switching
8.3 Weaknesses of the Smoking-Cessation Sector
8.3.1 Drugs Do Not Replace the Tactile and Oral Sensations Obtained from Smoking
8.3.2 Currently-Marketed Smoking-Cessation Therapies - Relapse Rate
8.4 Opportunities for the Smoking-Cessation Market
8.4.1 Smoking is Prevalent Worldwide and Slowly Increasing
8.4.2 Countries with Untapped Smoking-Cessation Market Potential
8.4.3 Growth of Emerging-Economy Smoking-Cessation Markets
8.4.4 Health Effects of Tobacco
8.4.5 Economic Impact of Tobacco Use
8.4.6 Framework Convention on Tobacco Control (FCTC)
8.4.7 Government-Sponsored Smoking-Cessation Programmes
8.4.8 Increasing Tobacco Taxes
8.4.9 Smoking Bans
8.4.10 Warning Information on Tobacco Products
8.4.11 Bans on Tobacco Advertising, Promotion and Sponsorship
8.5 Threats to the Smoking-Cessation Industry
8.5.1 Concern over Side-Effects of Smoking-Cessation Drugs
8.5.1.1 Champix/Chantix
8.5.1.2 Side-Effect Concerns for NRT and Bupropion
8.5.1.3 The Result of Side-Effect Concerns
8.5.2 Reimbursement for Smoking-Cessation Therapies
8.5.3 Traditional Smokeless Tobacco
8.5.3.1 Snus and Gutkha
8.5.3.2 Possible Impact of Greater Smokeless Tobacco Use
8.5.4 The E-Cigarette
8.5.4.1 The E-Cigarette Market
8.5.4.2 Will E-Cigarettes Revolutionise Tobacco Use and Pose a Threat to the Smoking-Cessation Market?
8.5.4.3 E-Cigarettes and Smoking-Cessation Therapies
9. Expert Interviews
9.1 Opinion on the Smoking-Cessation Sector from Dr Scott McIntosh, Director of the Greater Rochester Tobacco Research Center, USA, and Associate Director of the Smoking Research Program
9.1.1 Unmet Needs of the Smoking-Cessation Market
9.1.2 The Greatest Pharmacological Obstacles within the Smoking-Cessation Market
9.1.3 Drivers & Restraints of the Smoking-Cessation Market
9.1.4 Drugs and Smokeless Cigarettes
9.1.5 Are Vaccines More Effective than NRTs?
9.2 Opinion on Nicotine Vaccines from Dr Raafat Fahim, President and Chief Executive Officer, Nabi Biopharmaceuticals
9.2.1 Vaccines in the Pipeline for Nicotine Addiction
9.2.2 NicVAX Nicotine Vaccine
9.2.3 Other Nicotine Vaccines
10. The Smoking-Cessation Pipeline
10.1 Novel Vaccines Will Target Nicotine Addiction
10.1.1 NicVAX (Nabi Biopharmaceuticals)
10.1.2 TA-NIC (Celtic Pharma)
10.1.3 Niccine (Independent Pharmaceutica)
10.2 Monoamine Oxidase Inhibitors
10.2.1 EVT 302 (Evotec)
10.2.2 Selegiline (National Institute on Drug Abuse [NIDA])
10.3 Glycine Antagonists
10.4 Opiate Antagonists and Agonists
10.5 Dopamine D3 Antagonists
10.6 Nicotinic Ligands
10.7 Dopamine Uptake Inhibitors
10.8 Cannabinoid Receptor 1 Antagonists
11. Conclusions
11.1 Smoking is One of the Gravest Threats to Health Worldwide
11.2 Smoking Cessation
11.3 The Smoking-Cessation Market in 2010
11.4 World Smoking-Cessation Market: Prospects from 2010 to 2025
11.5 Leading and Emerging Smoking-Cessation Markets
11.6 Concluding Thoughts on the Market
List of Tables
Table 3.1 Nicotine Replacement Therapy Types, 2009
Table 3.2 Nicorette NRT Brands (Johnson & Johnson/Takeda), 2009
Table 3.3 Nicabate/NicoDerm/Nicorette/NiQuitin NRT Brands (GSK), 2009
Table 3.4 Novartis NRT Brands, 2009
Table 3.5 Other NRT Brands, 2009
Table 3.6 Key Drugs Prescribed Off-Label for Smoking Cessation, 2009
Table 4.1 World Smoking-Cessation Market: Sales, 2008-2009
Table 4.2 Leading Smoking-Cessation Product Types: Sales and Market Shares, 2008-2009
Table 4.3 Leading Smoking-Cessation Brands: Sales and Market Shares, 2009
Table 4.4 Leading Manufacturers of Smoking-Cessation Products: Sales and Market Shares, 2009
Table 4.5 World Smoking-Cessation Market: Sales Forecast, 2010-2016
Table 4.6 World Smoking-Cessation Market: Sales Forecast, 2017-2025
Table 4.7 Smoking-Cessation Product Type: Sales Forecasts, 2010-2016
Table 4.8 Smoking-Cessation Product Type: Sales Forecasts, 2017-2025
Table 5.1 Individual NRT Sales: Forecasts with Total Market, 2010-2016
Table 5.2 Individual NRT Sales: Forecasts with Total Market, 2017-2025
Table 6.1 Leading Smoking-Cessation Country Markets: Sales, 2009
Table 6.2 Smoking-Cessation Country Markets: Sales Forecasts, 2010-2016
Table 6.3 Smoking-Cessation Country Markets: Sales Forecasts, 2017-2025
Table 8.1 SWOT Analysis of the World Smoking-Cessation Market, 2010-2025
Table 10.1 Key Smoking-Cessation Pipeline Products, 2009
Table 11.1 Smoking-Cessation Country Markets: Sales Forecasts, Market Shares and CAGRs, 2009-2025
List of Figures
Figure 4.1 Leading Smoking-Cessation Product Types: Market Shares, 2009
Figure 4.2 Leading Smoking-Cessation Product Types: Market Shares, 2009
Figure 4.3 Leading Smoking-Cessation Brands: Market Shares, 2009
Figure 4.4 Leading Manufacturers of Smoking-Cessation Products: Market Shares, 2009
Figure 4.5 World Smoking-Cessation Market: Sales Forecast, 2010-2025
Figure 4.6 Product Type: Sales Forecast, 2010-2025
Figure 4.7 Product Type: Sales and Market Shares, 2008, 2010, 2015, 2025
Figure 5.1 NRT Market Sales: Forecast, 2010-2025
Figure 5.2 Upper Level NRT Individual Sales: Forecasts, 2010-2025
Figure 5.3 Lower Level NRT Individual Sales: Forecasts, 2010-2025
Figure 5.4 Individual NRT Market Shares, 2010
Figure 5.5 Individual NRT Market Shares, 2015
Figure 5.6 Individual NRT Market Shares, 2025
Figure 5.7 Chantix/Champix Sales Forecast, 2010-2025
Figure 5.8 Bupropion Sales Forecast, 2010-2025
Figure 6.1 Smoking-Cessation Market Shares by Country, 2009
Figure 6.2 Smoking-Cessation Market Shares by Country, 2010
Figure 6.3 Smoking-Cessation Market Shares by Country, 2015
Figure 6.4 Smoking-Cessation Market Shares by Country, 2025
Figure 6.5 US Smoking-Cessation Market: Sales Forecast, 2010-2025
Figure 6.6 UK Smoking-Cessation Market: Sales Forecast, 2010-2025
Figure 6.7 Canadian Smoking-Cessation Market: Sales Forecast, 2010-2025
Figure 6.8 Japanese Smoking-Cessation Market: Sales Forecast, 2010-2025
Figure 6.9 French Smoking-Cessation Market: Sales Forecast, 2010-2025
Figure 6.10 Swedish Smoking-Cessation Market: Sales Forecast, 2010-2025
Figure 6.11 Danish Smoking-Cessation Market: Sales Forecast, 2010-2025
Figure 6.12 German Smoking-Cessation Market: Sales Forecast, 2010-2025
Figure 7.1 World Smoking-Cessation Markets: CAGRs, 2009-2025
Figure 7.2 Indian Smoking-Cessation Market: Sales Forecast, 2010-2025
Figure 7.3 Chinese Smoking-Cessation Market: Sales Forecast, 2010-2025
Figure 11.1 World Smoking-Cessation Market: Sales Forecast, 2010-2025
発刊日
2010/01/13
体裁
PDF / 123ページ
販売価格
1,499GBP
発行
Visiongain
備考
※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。
関連カテゴリ
購入・お問い合わせ
